Zembrin
Natural health product licensed in Canada
- Licence holder
- HG&H Pharmaceuticals (Pty) Ltd.
- NPN or DIN-HM
- 80088325
- Status
- Active licence
- Licence date
- 12 September 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sceletium tortuosum Source : Sommité Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 50 mg Potency : 4 % Alkaloids | 25 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Acide stéarique, Stéarate de magnésium, Gélatine, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps support cognitive function in adults Helps to support cognitive performance in a healthy aging population
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult your health care practitioner prior to use if you are taking anxiolytics, MAO inhibitors, antidepressant medications (e.g. selective serotonin reuptake inhibitors (SSRI)), or phosphodiesterase type 4 (PDE4) inhibitors.
Source
Official Health Canada record, licence 80088325
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.